Compare CRIS & JF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRIS | JF |
|---|---|---|
| Founded | 2000 | 2012 |
| Country | United States | China |
| Employees | N/A | 30 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 19.1M |
| IPO Year | 2000 | N/A |
| Metric | CRIS | JF |
|---|---|---|
| Price | $4.63 | $0.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 7.6M | 5.7K |
| Earning Date | 05-07-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | $27.10 | N/A |
| Revenue Next Year | $67.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.18 | $0.89 |
| 52 Week High | $6.74 | $1.19 |
| Indicator | CRIS | JF |
|---|---|---|
| Relative Strength Index (RSI) | 73.85 | 44.85 |
| Support Level | $0.75 | $0.91 |
| Resistance Level | $6.74 | $1.02 |
| Average True Range (ATR) | 0.44 | 0.05 |
| MACD | 0.30 | -0.01 |
| Stochastic Oscillator | 66.77 | 30.66 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
J and Friends Holdings Ltd providing merchant digitalization and commerce-enablement solutions to small and medium enterprises (SME). Its solutions feature critical functionality that SMEs need to engage with consumers, manage their operations, accept payments, and grow their business. Such solutions empower single- and multi-location retailers, restaurants, and other SMEs to compete successfully in an omni-channel market environment by engaging with consumers across online, mobile, and physical channels. The group conducts all of its current operations in Australia and generates revenues from continuing operations are derived from within Australia.